Research and Development Expenses Credit (280-RICR-20-20-2)

The Research and Development Expenses Credit (280-RICR-20-20-2) is a tiered Rhode Island tax incentive that rewards businesses for increasing their qualified research spending within the state. It allows eligible entities to reduce their corporate or personal income tax liability based on the excess of current-year Rhode Island research expenditures over a defined base amount.

Regulatory Framework and Administrative Context

The Rhode Island Research and Development Expenses Credit is a sophisticated fiscal mechanism designed to integrate state-level economic development goals with federal technical standards. Administered by the Rhode Island Division of Taxation under the Department of Revenue, the credit is governed by both the Rhode Island General Laws (RIGL) and the Rhode Island Code of Regulations (RICR). Specifically, 280-RICR-20-20-2 provides the administrative details necessary to implement the broad mandates found in RIGL § 44-32-3. This regulatory structure ensures that while the state maintains autonomy over its revenue impacts, it leverages the established federal definitions of qualified research to provide a predictable environment for taxpayers.

The history of 280-RICR-20-20-2 reveals a continuous effort to refine the incentive. The rule has undergone several iterations, including periodic refiles and technical revisions, such as the major refile effective January 4, 2022, which succeeded a long-standing version that had been in place since 2003. These revisions typically reflect legislative changes or the need for updated filing procedures. The primary objective remains the same: to incentivize the “experimental or laboratory” activities that drive modern industrial growth. Unlike broader investment credits, the R&D Expense Credit is specifically targeted at the labor and material costs of innovation, rather than just capital assets.

For a business to successfully claim this credit, it must understand the interplay between various state agencies. While the Division of Taxation handles the tax filings and audits, the legal definitions often ripple through other departments. For example, the Rhode Island Commerce Corporation may be involved in certifying related incentives, though the R&D Expense Credit itself is generally a self-certified credit reported on the standard business entity tax return. The context of the credit is further enriched by specialized regulations like 280-RICR-20-70-59, which provides a parallel sales and use tax exemption for research equipment, creating a comprehensive “innovation package” for firms operating in the state.

Statutory Foundation and Legal Authority

The legal bedrock of the incentive is RIGL § 44-32-3, which establishes the fundamental right of a taxpayer to claim a credit against the taxes imposed by Chapter 11 (Business Corporation Tax), Chapter 17 (Taxation of Insurance Companies), or Chapter 30 (Personal Income Tax). This wide applicability ensures that various business forms—from large C-corporations to small partnerships and sole proprietorships—can benefit from the credit.

Core Statutory Requirements

The statute defines the credit as a percentage of the “excess” of qualified research expenses for the taxable year over the “base period research expenses”. This incremental design is crucial; the state does not simply subsidize all research, but rather rewards growth in research intensity. The law explicitly requires that these expenses must have been “incurred in this state” and must have occurred after July 1, 1994. This geographic nexus is the most critical constraint for taxpayers who operate in multiple jurisdictions. If a scientist’s salary is paid for research conducted in a Massachusetts laboratory, those wages cannot be included in the Rhode Island credit calculation, even if the company is headquartered in Providence.

The statute also addresses the treatment of property and casualty insurance companies. In a notable expansion of the typical R&D definition, § 44-32-3(b)(2) allows these companies to include expenditures for research into methods of preventing or reducing losses from fire and other perils. This reflects a legislative recognition that risk mitigation and loss prevention research is a vital form of innovation within the insurance sector, which has a significant historical presence in Rhode Island.

Tiered Rate Structure

The most distinctive feature of the Rhode Island R&D Expense Credit is its tiered rate structure, which was introduced for periods starting January 1, 1998. The legislature moved away from a flat 5% credit to a more generous but graduated system intended to provide a higher marginal benefit for smaller-scale research investments.

Expenditure Tier	Threshold	Credit Rate
Tier 1	First $111,111 of excess expenses	22.5%
Tier 2	Excess expenses over $111,111	16.9%

This tiered approach effectively creates a high-impact incentive for early-stage startups and small businesses. A company that increases its R&D spending by $100,000 receives a $22,500 credit, whereas a larger firm spending millions in excess of its base will see its effective rate converge toward the 16.9% mark. This structure aligns with the state’s goal of fostering a vibrant startup ecosystem in sectors like biotechnology, information technology, and marine sciences.

Federal Alignment and the Four-Part Test

Rhode Island law explicitly states that “qualified research expenses” (QREs) and “base period research expenses” shall have the same meaning as defined in 26 U.S.C. § 41, the federal R&D tax credit statute. By adopting the federal definitions, Rhode Island simplifies the compliance burden for taxpayers, allowing them to utilize the same data gathered for federal Form 6765.

Qualified Research Activities

To qualify for the credit, an activity must meet the federal “Four-Part Test” established under IRC § 41(d). The Division of Taxation audits these claims by looking for documentation that supports these four criteria:

1. Section 174 Test: The expenditures must be eligible for treatment as expenses under IRC § 174, meaning they must be incurred in connection with the taxpayer’s trade or business and represent research and development costs in the experimental or laboratory sense.
2. Technological in Nature Test: The research must be undertaken to discover information that is technological in nature. This means the process of experimentation must fundamentally rely on the principles of physical or biological sciences, engineering, or computer science.
3. Business Component Test: The taxpayer must intend to use the information discovered to develop a new or improved business component. A business component can be any product, process, computer software, technique, formula, or invention to be held for sale, lease, or license, or used by the taxpayer in its trade or business.
4. Process of Experimentation Test: Substantially all of the activities must constitute a process of experimentation. This involves the identification of uncertainty regarding the development or improvement of a business component, the identification of one or more alternatives intended to eliminate that uncertainty, and the evaluation of those alternatives through modeling, simulation, or systematic trial and error.

Excluded Activities

While the definition of qualified research is broad, both federal and Rhode Island law specify several exclusions. Research conducted after the beginning of commercial production, research adapting an existing product to a particular customer’s need, and duplication of an existing product are generally ineligible. Additionally, surveys, studies, social science research, and research conducted outside the United States (or in this case, outside Rhode Island) are excluded.

Internal-use software is subject to a “high-threshold-of-innovation” (HTI) test. For software developed primarily for a taxpayer’s internal use to qualify, it must not only meet the four-part test but also be innovative, involve significant economic risk, and not be commercially available for use by the taxpayer. This is a common point of contention in state audits, particularly for financial services and insurance firms that develop proprietary platforms.

Detailed Analysis of Calculation Mechanics

The calculation of the Rhode Island R&D Expense Credit is a multi-step process that begins with federal excess expenses and then applies state-specific geographic and rate-based filters. The Division of Taxation provides Form RI-7695E as the primary instrument for this calculation.

The Incremental Methodology

The credit is not based on total research spending, but on the increase in spending. This is determined by comparing current-year QREs to a “base amount.” Rhode Island follows the federal methodology for determining the base amount, which for established companies is typically the product of the “fixed-base percentage” and the average annual gross receipts for the preceding four years. For startups, the federal code provides a specific phase-in schedule for the fixed-base percentage, starting at 3%.

The credit is calculated using the following steps, as outlined in the instructions for Form RI-7695E:

1. Identify the Federal Qualified Research Expenses from Federal Form 6765, Line 5 or Line 20.
2. Identify the Federal Base Amount from Federal Form 6765, Line 8, 10, or 22.
3. Calculate the Federal Excess Expenses by subtracting the Base Amount from the QREs.
4. Apportion the excess to Rhode Island by determining the portion of the Federal Excess Expenses that were “incurred in this state” after July 1, 1994.
5. Apply the tiered rates: multiply the first $111,111 by 22.5% and any remaining amount by 16.9%.

Calculation of Credit Example

Consider “TechRI Corp,” a software development firm located entirely in Providence. For the 2024 tax year, TechRI Corp has the following research profile:

Metric	Amount
Federal Qualified Research Expenses	$500,000
Federal Base Amount	$300,000
Federal Excess Expenses	$200,000
Rhode Island Portion of Excess (100% in RI)	$200,000

The credit would be calculated using the tiered formula:

Credit = ($111,111 x 0.225) + (($200,000 – $111,111) x 0.169)

Credit = $25,000.00 + ($88,889 x 0.169)

Credit = $25,000.00 + $15,022.24

Credit = $40,022.24

In this example, TechRI Corp generates a total Rhode Island R&D Expense Credit of $40,022.24 for the year 2024.

Limitations and Carryover Provisions

Generating a credit is only the first half of the process; the second half involves the limitations on the taxpayer’s ability to use that credit to offset actual tax liability. Rhode Island imposes two primary caps on the credit’s utilization in any single tax year.

The 50% Tax Liability Limitation

Under RIGL § 44-32-3(c) and 280-RICR-20-20-2.5, the credit cannot reduce the tax due for a single year by more than 50% of the tax liability that would otherwise be payable. This limitation is applied after other credits that do not have such a cap, making the R&D credit a “middle-tier” credit in terms of the ordering rules. For example, if a company has a $50,000 tax liability and $15,000 in other credits, the 50% limit for the R&D credit is calculated on the remaining $35,000, allowing a maximum offset of $17,500.

The Corporate Minimum Tax Floor

For C-corporations and S-corporations, the credit cannot reduce the tax to less than the statutory minimum tax set forth in RIGL § 44-11-2(e). Since 2017, the minimum tax has been fixed at $400. This floor is absolute; even if a company has a massive R&D credit carryover, it must still pay the $400 minimum annual tax.

Seven-Year Carryover

If a taxpayer cannot use the full amount of the generated credit due to the 50% cap or the minimum tax floor, the unused portion can be carried forward for a maximum of seven years. This is notably shorter than the 20-year carryforward period allowed for the federal R&D credit, which means Rhode Island credits are at a higher risk of expiring unused if the company does not achieve sufficient profitability within the seven-year window. Taxpayers must maintain a schedule of carryovers, tracking the year of origination for each tranche of credit to ensure they are used in a first-in, first-out (FIFO) manner.

Administrative Guidance and Revenue Office Publications

The Rhode Island Division of Taxation provides several layers of guidance beyond the core regulations. These include Declaratory Rulings, Tax Advisories, and formal instructions on tax forms. This guidance is essential for interpreting ambiguous statutory terms like “incurred in this state”.

Declaratory Ruling 95-05: Proration and Base Amount

One of the most significant pieces of guidance is Ruling Request No. 95-05, issued shortly after the credit was established. A taxpayer requested a ruling on whether the base amount should be prorated if their first fiscal year after the law’s effective date (July 1, 1994) was less than twelve months.

The Tax Administrator ruled that the statute does not provide for or require proration of the base amount. Instead, the determinative factor is simply how much of the excess expenses were incurred in Rhode Island after July 1, 1994. The ruling provided multiple examples of how to calculate the credit for fiscal years that straddle the July 1 deadline, emphasizing that the credit is based on the timing of the expenses rather than a mathematical proration of the annual total.

Scenario	Total Federal Excess	Timing of RI Expenses	RI Credit Calculation
Case 1	$25,000	All incurred in March/April	$0 (Pre-July 1, 1994)
Case 2	$25,000	All incurred in November	$25,000 x 5% = $1,250
Even Spend	$25,000	Distributed throughout year	($25,000 x months after July 1) / 12

Note: These examples utilize the original 5% rate; modern calculations would substitute the tiered rates of 22.5% and 16.9%.

Advisory ADV 2025-18: Decoupling from Federal H.R. 1

A more recent and highly impactful piece of guidance is Advisory ADV 2025-18, which addresses Rhode Island’s response to federal tax law changes regarding research and experimental (R&E) expenditures. Under federal law (Public Law 119-21, or H.R. 1), businesses were temporarily allowed to accelerate the expensing of R&E costs, but Rhode Island has formally decoupled from this treatment for the 2025 tax year.

Consequently, Rhode Island taxpayers are required to amortize R&E expenditures for state tax purposes, even if they fully expensed them at the federal level. This requires the completion of RI Schedule 174A (Section 174A Amortization Worksheet) and an addback on the state tax return. This decoupling creates a permanent book-to-tax difference and increases the complexity of calculating the R&D credit, as the underlying “expenses” used for the credit may differ between the federal and state returns.

Business Structures and Pass-Through Entities

The R&D Expense Credit is designed to follow the flow of income in modern business structures. While C-corporations claim the credit directly on Form RI-1120C, other entities must utilize the pass-through mechanism.

Partnerships, Joint Ventures, and S-Corporations

In the case of a partnership, joint venture, or small business corporation (S-corp), the credit is divided among the partners or shareholders in the same manner as the entity’s income is divided. For example, if a partnership with three equal partners generates a $30,000 R&D credit, each partner is allocated $10,000 of the credit to be used against their personal Rhode Island income tax.

S-corporations and Limited Liability Companies (LLCs) treated as pass-through entities must file Form RI-1120S or RI-1065. These entities are generally subject to the $400 minimum tax, and the R&D credit cannot be used to reduce this entity-level fee. For tax years starting on or after January 1, 2025, the state has also adjusted the credit percentage for pass-through entities making the election to pay tax at the entity level, reducing the member-level credit from 100% to 90% of the tax paid.

Consolidated Returns and the “Silo” Rule

The Division of Taxation maintains a strict “silo” approach for consolidated corporate returns. Under 280-RICR-20-20-2.6, the credit is only allowed against the tax of the specific corporation within the consolidated group that actually qualified for the credit. It cannot be used to offset the tax of other corporations in the group, even if they are included in the same consolidated filing. This rule necessitates careful intra-entity planning for large corporate groups to ensure that R&D activities are located in the same legal entity that generates sufficient tax liability to utilize the credit.

Interaction with the Research and Development Property Credit

The R&D Expense Credit (§ 44-32-3) often operates alongside the R&D Property Credit (§ 44-32-2), but they are distinct incentives with different rules. The Expense Credit covers “intangible” costs like wages and supplies, while the Property Credit covers “tangible” costs like buildings and equipment.

The R&D Property Credit (§ 44-32-2)

The R&D Property Credit provides a 10% credit for the cost or other basis of tangible property and buildings that are used “principally for purposes of research and development in the experimental or laboratory sense”. To qualify, the property must be:

• Located in Rhode Island.
• Depreciable under IRC § 167 or § 168.
• Possess a useful life of three or more years.
• Acquired by purchase as defined in IRC § 179(d).

A crucial restriction is that the Property Credit cannot be claimed if the taxpayer also takes the elective deduction for the same property under § 44-32-1. Furthermore, the Property Credit carries an “addback” requirement: if the property is disposed of or ceases to be used for R&D purposes before the end of its useful life (or within 36 months for certain property), a portion of the credit must be added back to the tax in the year of disposition.

Ordering of Credits

Rhode Island regulation 280-RICR-20-20-2.5 and RIGL § 44-32-3(c) establish a specific order for using these credits. The Investment Tax Credit (§ 44-31-1) must be used first, followed by the R&D Property Credit (§ 44-32-2), and finally the R&D Expense Credit (§ 44-32-3). Because each of these credits (except the R&D Property Credit in certain corporate contexts) may be subject to a 50% tax liability cap, this ordering is vital. If the first two credits already reduce the tax liability to 50% of the original amount, the R&D Expense Credit must be carried forward to a future year.

Sales and Use Tax Exemption for R&D Equipment

Beyond the income tax credits, Rhode Island offers a significant sales and use tax exemption for research equipment under regulation 280-RICR-20-70-59. This regulation implements RIGL § 44-18-1 and provides a 100% exemption from sales tax for equipment used by “qualifying firms” for research and development purposes.

Eligibility and “Qualifying Firm”

A “qualifying firm” is a business for which the use of R&D equipment is an “integral part of its operations”. The definition of research and development for sales tax purposes is similar to the income tax definition, focusing on experimental or laboratory activity aimed at developing or improving products or processes. However, it explicitly excludes testing for quality control, management studies, or research in literary or historical projects.

Compliance and Certification

To receive the exemption, the firm must provide its suppliers with a Research and Development Exemption Certificate. If the equipment is used for both R&D and non-R&D purposes, the firm must:

1. Pay use tax on the portion of the equipment’s cost corresponding to the non-exempt use.
2. If the percentage of exempt use is unknown at the time of purchase, pay tax on the full cost and then perform an analysis 24 months later to determine the actual exempt usage.
3. Any balance due or credit resulting from this 24-month lookback must be reported on the next month’s use tax return, including interest from the time of original purchase.

This sales tax exemption provides immediate cash-flow benefits to research-intensive companies, complementing the long-term benefits of the income tax credits.

The 2025/2026 Sunset and Future Legislative Outlook

The landscape for Rhode Island R&D incentives is entering a period of contraction. The Fiscal Year 2026 Budget Bill, enacted in June 2025, includes several provisions that sunset or limit these historical incentives as part of a broader shift in state tax policy.

The Impact of the 2026 Budget Bill

Key changes affecting the research and development sector include:

• Sunset of the R&D Property Credit: Credits for research and development property acquired, constructed, or reconstructed after July 1, 1994, will no longer be allowed for tax years beginning on or after January 1, 2026.
• Sunset of the Elective Deduction: The elective deduction against net income for new R&D facilities (§ 44-32-1) is similarly sunset for tax years starting on or after January 1, 2026.
• Carryforward Preservation: While new property credits will not be authorized after the sunset, credits allowed for tax years ending on or before December 31, 2025, may still be carried forward into future years.
• Extension of NOL Carryforward: Offsetting these sunsets, the budget increases the number of years a business may carry forward a Net Operating Loss (NOL) from 5 years to 20 years, effective January 1, 2025. This provides companies with a longer-term tool to manage tax liabilities through periods of high R&D spending.

Analysis of the Policy Shift

The sunsetting of the R&D Property Credit suggests a move away from subsidizing the “bricks and mortar” of innovation in favor of more flexible or broad-based tax policies. For companies currently planning significant facility expansions or equipment upgrades, it is imperative to have that property “placed in service” before the end of 2025 to lock in the 10% credit. The retention of the R&D Expense Credit (though subject to its own evolving limitations) indicates that the state still values the labor-intensive portion of innovation, which aligns with its goals of job creation and talent retention.

Comparative Analysis of Credit Features

The following table summarizes the key distinctions between the different R&D-related tax benefits in Rhode Island as they stand in the 2024-2025 period.

Feature	R&D Expense Credit (§ 44-32-3)	R&D Property Credit (§ 44-32-2)	R&D Sales Tax Exemption (20-70-59)
Applicable Tax	Corporate/Personal Income	Corporate/Personal Income	Sales and Use Tax
Credit Rate	Tiered: 22.5% / 16.9%	Flat: 10%	100% Exemption
Base Period	Incremental (Excess only)	Total Cost/Basis	Total Purchase Price
Carryover	7 Years	7 Years	N/A (Point of Sale)
Sunset Date	Active (with 2026 limits)	January 1, 2026	Active
Primary Focus	Labor, Supplies, Contracts	Buildings, Equipment	Scientific Equipment

Strategic Planning and Audit Preparedness

Given the complexities of Rhode Island’s R&D tax regime, businesses must adopt a proactive approach to documentation and filing. The Division of Taxation increasingly focuses on the “nexus” of research, requiring firms to prove that the QREs claimed were truly incurred in the state.

Documentation Best Practices

Audit guidelines issued by the state and practitioners suggest several strategies for defending R&D claims:

• Project-Specific Accounting: Maintain a sub-ledger that tracks costs by project, allowing for the clear separation of Rhode Island-based projects from those conducted elsewhere.
• Contemporaneous Narratives: Prepare annual reports for each project that explicitly address the Four-Part Test, detailing the technical uncertainties and the specific process of experimentation used to resolve them.
• Wage Apportionment: For employees who travel between sites, maintain time-tracking data to justify the portion of their wages allocated to the Rhode Island credit.
• Form RI-7695E Retention: Keep detailed copies of the worksheets used to derive the Rhode Island portion of the federal excess, as this is the most common point of adjustment in a state audit.

Utilizing the Declaratory Ruling Process

For taxpayers facing unique circumstances or ambiguous fact patterns, the declaratory ruling process remains a valuable tool. Under 280-RICR-20-00-5, a taxpayer can request a binding explanation of how a statute or regulation applies to their specific facts. This is particularly useful for new industries (e.g., cannabis, which has recently seen decoupling from federal 280E restrictions in Rhode Island) or complex internal-use software projects.

Final Thoughts

The Rhode Island Research and Development Expenses Credit (280-RICR-20-20-2) is a pillar of the state’s innovation strategy, but its effectiveness depends on meticulous compliance and strategic timing. The tiered rate structure offers significant advantages for smaller firms, while the seven-year carryforward and 50% tax liability cap require careful long-term financial modeling.

As the state transitions into a new fiscal era with the 2026 sunsets, businesses should:

1. Accelerate Tangible Investments: Complete all R&D property acquisitions before December 31, 2025, to ensure eligibility for the 10% property credit before it expires.
2. Monitor H.R. 1 Decoupling: Use RI Schedule 174A to track and add back federal R&E expenses, ensuring that state income is correctly reported to avoid penalties.
3. Evaluate Pass-Through Elections: For S-corp and partnership owners, weigh the benefits of entity-level taxation against the reduced 90% member-level credit starting in 2025.
4. Engage with Local Guidance: Regularly review Division of Taxation Advisories and Newsletters, as they are the primary vehicle for announcing changes in audit focus or legislative interpretation.

By understanding the granular details of the Rhode Island R&D tax credit context, from the “Four-Part Test” of IRC § 41 to the “incurred in this state” mandate of RIGL § 44-32-3, taxpayers can maximize their incentives while contributing to the state’s scientific and technological advancement.